Addressing sorafenib resistance—a major barrier to effective treatment of hepatocellular carcinoma (HCC)—this study utilized patient-derived liver cancer stem cell (LCSC) models to elucidate the pivotal role of the transcription factor ASCL2 in maintaining stemness and driving drug resistance. Throu...
ORGANISM(S): Homo sapiens